Andrea Schaefer-Schuler

6PUBLICATIONS
5CO-AUTHORS
Gene and molecular therapyRadiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Instruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 08, 2026
Organ and tumor dosimetry of [161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC.

|May 04, 2026
Outcome and Safety of Radioligand Therapy With [ 161 Tb]Tb-PSMA-617 After Re-Progression in mCRPC Patients Previously Treated With [ 177 Lu]Lu-PSMA-617.

|May 13, 2025
PSMA Radioligand Therapy in Advanced Age: Insights From an 85y+ mCRPC Patient Cohort.

Moritz B Bastian, Benedikt Wörl, Arne Blickle

|Jan 09, 2025
225 Ac-PSMA-617 Augmentation After Insufficient Response Under 177 Lu-PSMA-617 Radioligand Therapy in mCRPC: Evaluation of Outcome and Safety From a Prospective Registry (REALITY Study).

Florian Rosar, Fadi Khreish, Lea Sophie Nagel

|Nov 27, 2024
Outcome and Renal Safety of PSMA-Targeted Radioligand Therapy in mCRPC Patients With Preexisting Impaired Renal Function.

Moritz B Bastian, Maike Sieben, Caroline Burgard

|May 05, 2021
Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy.

Florian Rosar, Niklas Schön, Hendrik Bohnenberger

Pageof 1

Frequent Collaborators

4 joint publications

Moritz B Bastian

4 joint publications

Samer Ezziddin

4 joint publications

Florian Rosar

2 joint publications

Caroline Burgard